about
Latanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost-effectiveness analysis.Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.Trends in Glaucoma Medication Expenditures under Universal Health Coverage: A National Population-Based Longitudinal Survey in Taiwan.Progress toward personalized medicine for glaucomaDaily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and SwedenPersonalized Prediction of Glaucoma Progression Under Different Target Intraocular Pressure Levels Using Filtered Forecasting Methods.
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The rising cost of glaucoma drugs.
@en
The rising cost of glaucoma drugs.
@nl
type
label
The rising cost of glaucoma drugs.
@en
The rising cost of glaucoma drugs.
@nl
prefLabel
The rising cost of glaucoma drugs.
@en
The rising cost of glaucoma drugs.
@nl
P2860
P356
P1476
The rising cost of glaucoma drugs.
@en
P2093
A Azuara-Blanco
P2860
P304
P356
10.1136/BJO.2005.079996
P407
P577
2006-02-01T00:00:00Z